Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CoronaVac induces lower neutralising activity against variants of concern than natural infection.
Vacharathit V, Aiewsakun P, Manopwisedjaroen S, Srisaowakarn C, Laopanupong T, Ludowyke N, Phuphuakrat A, Setthaudom C, Ekronarongchai S, Srichatrapimuk S, Wongsirisin P, Sangrajrang S, Imsuwansri T, Kirdlarp S, Nualkaew S, Sensorn I, Sawaengdee W, Wichukchinda N, Sungkanuparph S, Chantratita W, Kunakorn M, Rojanamatin J, Hongeng S, Thitithanyanont A. Vacharathit V, et al. Among authors: setthaudom c. Lancet Infect Dis. 2021 Oct;21(10):1352-1354. doi: 10.1016/S1473-3099(21)00568-5. Epub 2021 Aug 26. Lancet Infect Dis. 2021. PMID: 34454652 Free PMC article. No abstract available.
A Prospective Study of Cytomegalovirus-Specific Cell-Mediated Immune Monitoring and Cytomegalovirus Infection in Patients With Active Systemic Lupus Erythematosus Receiving Immunosuppressants.
Bruminhent J, Autto S, Rotjanapan P, Ngarmjanyaporn P, Bushyakanist A, Kirdlarp S, O-Charoen P, Setthaudom C, Pisitkun P. Bruminhent J, et al. Among authors: setthaudom c. Open Forum Infect Dis. 2021 May 16;8(6):ofab248. doi: 10.1093/ofid/ofab248. eCollection 2021 Jun. Open Forum Infect Dis. 2021. PMID: 34189173 Free PMC article.
Anti-SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report.
Boongird S, Chuengsaman P, Phanprasert S, Kitpermkiat R, Assanatham M, Nongnuch A, Kiertiburanakul S, Malathum K, Phuphuakrat A, Setthaudom C, Bruminhent J. Boongird S, et al. Among authors: setthaudom c. Kidney Int. 2021 Nov;100(5):1136-1138. doi: 10.1016/j.kint.2021.08.007. Epub 2021 Aug 19. Kidney Int. 2021. PMID: 34419552 Free PMC article. No abstract available.
SARS-CoV-2 neutralizing antibodies decline over one year and patients with severe COVID-19 pneumonia display a unique cytokine profile.
Vacharathit V, Srichatrapimuk S, Manopwisedjaroen S, Kirdlarp S, Srisaowakarn C, Setthaudom C, Inrueangsri N, Pisitkun P, Kunakorn M, Hongeng S, Sungkanuparph S, Thitithanyanont A. Vacharathit V, et al. Among authors: setthaudom c. Int J Infect Dis. 2021 Nov;112:227-234. doi: 10.1016/j.ijid.2021.09.021. Epub 2021 Sep 15. Int J Infect Dis. 2021. PMID: 34536610 Free PMC article.
SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients (CVIM 1 study).
Bruminhent J, Setthaudom C, Chaumdee P, Boongird S, Kiertiburanakul S, Malathum K, Nongnuch A, Phuphuakrat A, Jirasiritham S, Janphram C, Thotsiri S, Upama S, Assanatham M; Ramathibodi Transplant Infectious Diseases (RTID) Study Group. Bruminhent J, et al. Among authors: setthaudom c. Am J Transplant. 2022 Mar;22(3):813-822. doi: 10.1111/ajt.16867. Epub 2021 Dec 6. Am J Transplant. 2022. PMID: 34657386 Free PMC article.
Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine.
Boongird S, Chuengsaman P, Setthaudom C, Nongnuch A, Assanatham M, Phanprasert S, Kitpermkiat R, Kiertiburanakul S, Malathum K, Phuphuakrat A, Davenport A, Bruminhent J. Boongird S, et al. Among authors: setthaudom c. Infect Dis Ther. 2022 Feb;11(1):351-365. doi: 10.1007/s40121-021-00574-9. Epub 2021 Dec 3. Infect Dis Ther. 2022. PMID: 34859359 Free PMC article.
Comparison of the immunogenicity of ChAdOx1 nCoV-19 vaccine against the wild-type and delta variants in kidney transplant recipients and healthy volunteers.
Watcharananan SP, Jaru-Ampornpan P, Sahawongcharoen S, Naitook N, Himananto O, Jongkaewwattana A, Setthaudom C, Rattanasiri S, Phuphuakrat A, Thakkinstian A, Mavichak V; Praram 9-BIOTEC-Ramathibodi COVID-19 Vaccine Study Group. Watcharananan SP, et al. Among authors: setthaudom c. Am J Transplant. 2022 May;22(5):1459-1466. doi: 10.1111/ajt.16966. Epub 2022 Feb 12. Am J Transplant. 2022. PMID: 35090091 Free article.
Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients.
Bruminhent J, Setthaudom C, Kitpermkiat R, Kiertiburanakul S, Malathum K, Assanatham M, Nongnuch A, Phuphuakrat A, Chaumdee P, Janphram C, Thotsiri S, Chuengsaman P, Boongird S. Bruminhent J, et al. Among authors: setthaudom c. Sci Rep. 2022 Mar 4;12(1):3587. doi: 10.1038/s41598-022-07574-w. Sci Rep. 2022. PMID: 35246578 Free PMC article.
23 results